Author(s)
Koselerli R1, Caliskan Z2, Kuzucu G3, Gursoy K1, Ergun H4, Kaya Y5, Turkoglu S6, Dereli U7, Koksal T8, Deger C7, Dokuyucu O9, Saylan M10
1Turkish Social Security Institution, Ankara, Turkey, 2Hacettepe University, Ankara, Turkey, 3Lundbeck Turkey, Istanbul, Turkey, 4Ankara University, Ankara, Turkey, 5Bristol-Myers Squibb, Istanbul, Turkey, 6Nobel Pharma, Ankara, Turkey, 7Association of Research-Based Pharmaceutical Companies, Istanbul, Turkey, 8Pharmaceutical manufacturers association of Turkey, Ankara, Turkey, 9AMGEN, Istanbul, Turkey, 10Bayer AG Turkey, Istanbul, Turkey
OBJECTIVES: To understand the perspective of stakeholders about HTA related legislation and its actual implementation in Turkish setting and to discuss important issues reported by stakeholders regarding current practice of the HTA process. METHODS: One hundred and twenty ISPOR Turkish Chapter members from public, private health sectors and academicians were invited to complete an online survey consisting of 32 items within 12 domains: (1)explicitly stated objectives of HTA (2)positive effect on new technologies (3)collaboration with industry (4)usage of best available data for decisions (5)objectiveness and transparency (6)defined timing and processes (7)involvement of stakeholders (8)early engagement (9)independency of regulatory and reimbursement processes (10)consideration of societal and local issues (11)accountability and equitableness (12)adequacy of resources. All claims were evaluated from regulation and application perspectives using 3 level responses (valid, partially valid or not valid). RESULTS: Forty members completed the survey. Responders’ mean age was 38.8 years and they were mostly male (62.5%) and from the private sector. Three domains with lowest ratings were the adequacy of resources, consideration of societal and local issues and positive effect on new technologies in application. Three domains with highest ratings were objectiveness and transparency, defined timing and processes, independency of regulatory and reimbursement processes in written regulations. Although private health sector ratings were lower than public and academic ratings, results were generally consistent among different sectors. CONCLUSIONS: This survey showed that there are discrepancies between regulations and their implementation in practice in Turkey. Anonymous surveys can be useful to understand issues in a particular health technology assessment system. A workshop including all stakeholders to discuss possible solutions based on the survey results is planned by ISPOR Turkish Chapter.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PHP304
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
Multiple Diseases